Novartis to sell Themis diclofenac topical gel
Updated on 16 April 2013 Novartis India enter into a license and supply agreement to buy Themis Medicare's diclofenac topical gel, which is formulated using TPM transdermal drug delivery system Novartis India sell Themis Medicare's diclofenac topical gel. Themis Medicare, which is a partner firm of Australian drug delivery technology company Phosphagenics, entered into a license and supply agreement with Novartis India to sell its Themis diclofenac topical gel formulated using a unique TPM transdermal drug delivery system. The drug delivery system is available only with Themis in India. The information was revealed by Themis Medicare in a release to the Bombay Stock Exchange (BSE) post market on Friday, April 12, 2013. Phosphagenics welcomed the exciting commercial expansion and said that endorsement by Novartis India is a significant validation its TPM technology by a global pharmaceutical company.
http://www.biospectrumasia.com/biospectrum/news/187024/novartis-sell-themis-diclofenac-topical-gel#.UW-9tIwayK0
biospectrum asia
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.226K | 1.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 92468918 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 76402411 | 25 |
View Market Depth
| Last trade - 12.50pm 06/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |